We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
(+5.9%)
Cap. Flow
-$501M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$417M |
| 2 |
Meta Platforms (Facebook)
META
|
+$383M |
| 3 |
Amazon
AMZN
|
+$308M |
| 4 |
Microsoft
MSFT
|
+$293M |
| 5 |
GE Aerospace
GE
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$312M |
| 2 |
Bank of America
BAC
|
+$292M |
| 3 |
ExxonMobil
XOM
|
+$274M |
| 4 |
lululemon athletica
LULU
|
+$238M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.05% |
| 2 | Technology | 14.35% |
| 3 | Consumer Discretionary | 13.97% |
| 4 | Financials | 9.9% |
| 5 | Industrials | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Globant
GLOB
$1.41B
| $7.97M | 0.02% |
48,613
+24,746
| +104% | +$4.04M |
|
777
Waste Management
WM
$95.5B
| $7.96M | 0.02% |
48,754
-11,430
| -19% | -$1.75M |
|
|
ASRT
778
DELISTED
Assertio
ASRT
| $7.92M | 0.02% |
82,885
+38,316
| +86% | +$2.89M |
|
779
Enphase Energy
ENPH
$5.01B
| $7.91M | 0.02% |
37,624
-738,185
| -95% | -$160M |
|
780
Lyft
LYFT
$5.73B
| $7.9M | 0.02% |
852,450
-560,191
| -40% | -$6.77M |
|
781
Fox Class B
FOX
$21.3B
| $7.89M | 0.02% |
251,946
+32,673
| +15% | +$1.02M |
|
|
HAPN
782
Happen Inc
HAPN
$2.16B
| $7.86M | 0.02% |
1,089,917
+232,621
| +27% | +$2.07M |
|
783
Mattel
MAT
$4.3B
| $7.85M | 0.02% |
+426,536
| New | +$7.92M |
|
784
Stanley Black & Decker
SWK
$14.6B
| $7.85M | 0.02% |
+97,427
| New | +$8.2M |
|
785
UiPath
PATH
$6.02B
| $7.79M | 0.02% |
+443,800
| New | +$6.71M |
|
|
APGB
786
DELISTED
Apollo Strategic Growth Capital II
APGB
| $7.77M | 0.02% |
758,373
-3,038,960
| -80% | -$30.8M |
|
|
LCW
787
DELISTED
Learn CW Investment Corporation Class A Ordinary Shares
LCW
| $7.74M | 0.02% |
753,652
| – | – |
|
788
Cardinal Health
CAH
$53.7B
| $7.74M | 0.02% |
102,493
-304,084
| -75% | -$22.9M |
|
789
Karyopharm Therapeutics
KPTI
$161M
| $7.72M | 0.02% |
132,327
-15,021
| -10% | -$741K |
|
|
CORS
790
DELISTED
Corsair Partnering Corporation
CORS
| $7.63M | 0.02% |
747,515
-425,613
| -36% | -$4.31M |
|
791
State Street SPDR S&P Biotech ETF
XBI
$10.2B
| $7.63M | 0.02% |
+100,120
| New | +$8.31M |
|
792
Fox Class A
FOXA
$23.8B
| $7.61M | 0.02% |
223,445
-233,663
| -51% | -$7.89M |
|
|
TCOA
793
DELISTED
Zalatoris Acquisition Corp.
TCOA
| $7.6M | 0.02% |
742,500
| – | – |
|
794
Acrivon Therapeutics
ACRV
$66.8M
| $7.58M | 0.02% |
597,469
-625,783
| -51% | -$10.5M |
|
|
JAQC
795
DELISTED
Jupiter Acquisition Corporation Common stock
JAQC
| $7.58M | 0.02% |
746,578
| – | – |
|
|
ZINGW
796
CALL
DELISTED
FTAC Zeus Acquisition Corp. Warrant
ZINGW
| $7.56M | 0.02% |
735,000
| – | – |
|
|
EXAI
797
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $7.55M | 0.02% |
1,425,148
-242,824
| -15% | -$1.65M |
|
798
Bentley Systems
BSY
$10.2B
| $7.54M | 0.02% |
175,443
-364,856
| -68% | -$14.5M |
|
799
CALL
PepsiCo
PEP
$191B
| $7.53M | 0.02% |
41,300
+1,600
| +4% | +$280K |
|
800
PUT
Mastercard
MA
$487B
| $7.52M | 0.02% |
20,700
+11,500
| +125% | +$4.18M |
|
Similar funds
Marshall Wace's Q1 2023 Portfolio in Review
As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
- Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
- Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
- Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
- Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
- Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
- Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.
Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.